Validation and Comparison of Prognostic Models in Renal Carcinoma in a Tertiary Hospital.

Autor: Sanz Del Pozo M; Urology Department, Miguel Servet University Hospital, 50009 Zaragoza, Spain.; URO-SERVET, Emerging Research Group, Aragón Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain.; INDIVO Research Group, Research in New Targets in Autoimmunity and Oncological Surveillance, San Jorge University (USJ), 50830 Zaragoza, Spain., Orlandi Oliveira W; Urology Department, Juan Ramón Jiménez Hospital, 21005 Huelva, Spain., Linacero Gracia Á; INDIVO Research Group, Research in New Targets in Autoimmunity and Oncological Surveillance, San Jorge University (USJ), 50830 Zaragoza, Spain.; Faculty of Health Sciences, San Jorge University (USJ), 50820 Zaragoza, Spain., Sánchez Zalabardo JM; Urology Department, Miguel Servet University Hospital, 50009 Zaragoza, Spain.; URO-SERVET, Emerging Research Group, Aragón Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain.; INDIVO Research Group, Research in New Targets in Autoimmunity and Oncological Surveillance, San Jorge University (USJ), 50830 Zaragoza, Spain., Gil Sanz MJ; Urology Department, Miguel Servet University Hospital, 50009 Zaragoza, Spain.; URO-SERVET, Emerging Research Group, Aragón Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Sáez Gutiérrez MB; INDIVO Research Group, Research in New Targets in Autoimmunity and Oncological Surveillance, San Jorge University (USJ), 50830 Zaragoza, Spain.; Faculty of Health Sciences, San Jorge University (USJ), 50820 Zaragoza, Spain., Borque Fernando Á; Urology Department, Miguel Servet University Hospital, 50009 Zaragoza, Spain.; URO-SERVET, Emerging Research Group, Aragón Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain.

Publikováno v: Archivos espanoles de urologia [Arch Esp Urol] 2024 Jul; Vol. 77 (6), pp. 622-631.